Zeposia’s Ulcerative Colitis Approval Provides BMS’s Beachhead Into GI

 
• By Joseph Haas
FDA approved background, 3D rendering, blue street sign
Ulcerative colitis is Zeposia's second US indication

More from New Products

More from Scrip